Systematic review / meta-analysis / 2011
Prediabetes interventions prevented diabetes but did not reduce total or cardiovascular mortality
A meta-analysis of 10 randomized trials encompassing 23,152 participants followed for an average of 3.75 years evaluated prediabetes therapies. Interventions reduced diabetes incidence versus controls (risk ratio 0.83, 95% CI 0.80-0.86), with non-drug approaches showing superior efficacy to drug treatments (0.52 vs 0.70, P < 0.05). However, no differences appeared for all-cause mortality (0.96, 0.84-1.10) or cardiovascular death (1.04, 0.61-1.78), while stroke risk showed a borderline reduction (0.76, 0.58-0.99).
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 23,152 patients with prediabetes across 10 randomized controlled trials
- What was measured
- Progression to diabetes, all-cause mortality, and cardiovascular events
THE PAPER
Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials.
Hopper I, Billah B, Skiba M, Krum H. Eur J Cardiovasc Prev Rehabil, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.